Contraceptive Technology Update – August 1, 2015
August 1, 2015
View Issues
-
Research adds more insight into newer OCs and risk of VTE
Results from two United Kingdom population-based, case-control nested studies using two large primary care databases indicate risks of venous thromboembolism associated with combined oral contraceptives were, with the exception of norgestimate, higher for newer drug preparations than for second-generation drugs.
-
New research indicates promise of nine-valent human papillomavirus vaccine
The recently approved nine-valent human papillomavirus vaccine potentially can prevent 80% of cervical cancers in the United States if given to all 11- or 12-year-old children before they are exposed to the virus, results of a new seven-center study suggest.
-
Time to change Medicaid sterilization wait period
U.S. health policy requires Medicaid beneficiaries to wait 30 days before tubal sterilization. In a journal analysis, national experts argue that this practice violates healthcare justice, as elective tubal sterilization is readily available to women with a private source of payment.
-
Research indicates text messages can aid adolescent adherence to contraceptive use
Sending teen girls periodic text messages reminding them to follow through on their clinic appointments for periodic birth control injections aids in improving timing and adherence to contraception, research indicates.
-
At least 20 insurers aren’t offering Affordable Care Act’s breastfeeding benefits
Breastfeeding rates continue to rise. In 2011, 79% of U.S. newborn infants started to breastfeed, according to the Centers for Disease Control and Prevention.
-
Are women getting screened for osteoporosis? Just-released research suggests answer is ‘no’
Too few women at high risk for osteoporosis are being tested for the condition, while too many women at low risk are being screened, results of a California-based study suggest.